The main outcome indicators included liver function indexes, such as ALT, AST, and alkaline phosphatase (ALP), and liver fibrosis indexes, such as collagen, area of collagen fibrosis in the liver (%), α-smooth muscle actin (α-SMA), hyaluronidase (HA), laminin (LN), precollagen type III (PCIII), and hydroxyproline (Hyp). The gene discussed is GPT; the disease is fibrosis.